Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth- Technavio

MLA

“Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to Grow by USD 6.75 Billion from 2024 to 2028, North America to Account for 40% of Market Growth- Technavio.” PR Newswire, 30 Oct. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.770838829&authtype=sso&custid=ns315887.

APA

Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth- Technavio. (2023, October 30). PR Newswire.

Chicago

PR Newswire. 2023. “Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to Grow by USD 6.75 Billion from 2024 to 2028, North America to Account for 40% of Market Growth- Technavio,” October 30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.770838829&authtype=sso&custid=ns315887.